Vestiq Pharmaceuticals, Inc. launches with agenda for rapid growth, acquires NDAs for ORAVIG® and Zuplenz® oral soluble film
16 January 2013 | By WHITECOAT Strategies, LLC
Vestiq announces its launch of products...
List view / Grid view
News
Lonza and BaroFold announce a technology evaluation agreement for PreEMT™
Lonza, a leader in biological development and BaroFold, Inc., an innovative protein technology developer, announced today a non-exclusive technology and license agreement whereby Lonza will evaluate BaroFold’s PreEMT™ high pressure refolding technology for use in biological development refolding processes.
European Commission approves PREZISTA® (darunavir) 800mg tablet once a day
16 January 2013 | By prnewswire.co.uk
The European Commission has approved a new PREZISTA® (darunavir) 800mg tablet...
Amgen announces top-line results of Phase 3 Aranesp® (darbepoetin alfa) RED-HF® trial
16 January 2013 | By Amgen
Amgen announced top-line results of the Phase 3 Aranesp® RED-HF® Trial...
Daiichi Sankyo and Ranbaxy to leverage synergies in Thailand
16 January 2013 | By Daiichi Sankyo
Daiichi Sankyo and Ranbaxy announced their intention to integrate their business operations in Thailand...
Biogen Idec and Elan submit applications for first-line use of TYSABRI in anti-JCV antibody negative patients with MS
16 January 2013 | By Biogen Idec
Biogen Idec and Elan have submitted applications to the U.S. FDA...
U.S. FDA grants priority review to Boehringer Ingelheim’s Afatinib* NDA for EGFR mutation-positive advanced NSCLC
16 January 2013 | By Boehringer Ingelheim
The acceptance of the NDA filing reinforces our ongoing commitment to oncology..."
Amgen to build state-of-the-art manufacturing facility in Singapore
16 January 2013 | By Amgen
Amgen announced plans to build a new manufacturing facility in the Tuas Biomedical Park area of Singapore...
AstraZeneca announces changes to Senior Executive Team
15 January 2013 | By AstraZeneca
AstraZeneca unveiled changes to its executive leadership team...
Daiichi Sankyo and ArQule announce top-line results of Phase 2 trial with tivantinib in colorectal cancer
15 January 2013 | By Daiichi Sankyo
“We are encouraged by these findings..."
Change to the Roche Corporate Executive Committee
15 January 2013 | By Roche
John C. Reed, M.D., Ph.D., has been appointed Head of Roche pRED and member of the enlarged Corporate Executive Committee...
New 1.3-micron Kinetex core-shell media delivers superior UHPLC performance
15 January 2013 | By Phenomenex
“The Kinetex product line spans our customers’ needs..."
Patient groups give Lundbeck top marks
14 January 2013 | By H. Lundbeck A/S
Lundbeck took first place in a global survey, in which 600 patient groups around the world evaluated the ability of 29 pharmaceutical companies to meet patient expectations...
Pivotal study in The Lancet shows potential of Novartis vaccine Bexsero® to help provide broad protection to infants against MenB
14 January 2013 | By Novartis
Findings from a pivotal Phase III clinical trial...
Regulatory update – GSK announces submission of albiglutide BLA to the US FDA for the treatment of type 2 diabetes
14 January 2013 | By GlaxoSmithKline
Albiglutide is not yet approved as a treatment for type 2 diabetes...
